Search | Search by Center | Search by Source | Keywords in Title
Russo P, Smith MW, Namjoshi M. Changes in schizophrenia-related total direct medical costs following initiating of olanzapine or resperidone in a privately insured population in the United States. Paper presented at: Collegium Internationale Neuro-Psychopharmacolgicum Annual Congress; 2002 Feb 1; Montréal, Canada.